Thursday 23rd March 2023
Companion diagnostics for precision medicine
Royal Society of Chemistry, London
This one-day symposium will address the development and need for companion diagnostics (CDx) for precision medicine applications. Companion diagnostics are becoming more and more important with time together with the growth of targeted therapies. Precision medicine approach aims to stratify patients with the ultimate aim of targeting patients who are most likely to respond to a specific treatment. Currently, CDx are used for many diseases lung cancer, colorectal cancer, breast cancer and melanoma.

At this symposium, delegates will be able to explore the current state of the art in vitro diagnostic tests used by the industry and explore the different scientific measurements that are needed to develop and deliver a CDx into the market.

CDx is a platform technology and can be used for many other diseases, join us and lets discuss the future of healthcare and personalised treatment.

Online attendance option is available in this meeting via MS Teams.

If you have a NHS/MHRA/academia e-mail address, you may be eligible for a £50 discount for this meeting. Please contact events@jpag.org for further details.

Speakers:
Prof George Hanna - Imperial College London
Graham Fews - West Midlands Regional Genetics Lab / NHS
Prof Lorna Harries - University of Exeter / SENISCA
Dr Stephen Little - Yourgene Health
Dr Dahlia Salman - Bioxhale ltd
Dr Paul Wilson - Intelligent Fingerprinting
Dr Elizabeth Young - NHS
Prof Philip Young - University of Warwick